💼 Business 1d ago

FDA approves daily HIV pill from Gilead designed to simplify treatment for some patients

CNBC Business
CNBC business news
View Channel →
Source ↗ 👁 1 💬 0
The new pill is also aimed at people who are doing well on a single-tablet regimen, including Biktarvy, and want to switch to a new treatment.

Comments (0)

Sign in to join the discussion

More Like This

📰
Gap shares jump 12% after company names new Old Navy CEO to revive struggling brand
Business News · 1d ago
'Cowboy builders' targeted in new government clampdown
BBC News · 1d ago
Rivian stock falls as CFO Claire McDonough to step down
All News · 1d ago
Anthropic explored MatX acquisition for chip development - Reuters
All News · 1d ago
Activist investor Carl Icahn returns JetBlue board seats
All News · 1d ago
Earnings call transcript: Ulta Beauty beats Q2 2026 estimates, shares fall
All News · 1d ago